211 related articles for article (PubMed ID: 18398806)
41. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
42. Regional fat distribution and cardiometabolic risk in healthy postmenopausal women.
Peppa M; Koliaki C; Hadjidakis DI; Garoflos E; Papaefstathiou A; Katsilambros N; Raptis SA; Dimitriadis GD
Eur J Intern Med; 2013 Dec; 24(8):824-31. PubMed ID: 24169066
[TBL] [Abstract][Full Text] [Related]
43. Associations of the limb fat to trunk fat ratio with markers of cardiometabolic risk in elderly men and women.
Saunders TJ; Davidson LE; Janiszewski PM; Després JP; Hudson R; Ross R
J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1066-70. PubMed ID: 19561143
[TBL] [Abstract][Full Text] [Related]
44. [The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk].
Vatier C; Antuna-Puente B; Fellahi S; Vigouroux C; Capeau J; Bastard JP;
Ann Biol Clin (Paris); 2020 Jun; 78(3):265-268. PubMed ID: 32420886
[TBL] [Abstract][Full Text] [Related]
45. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert EA; Straznicky NE; Dixon JB; Lambert GW
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H244-58. PubMed ID: 25980020
[TBL] [Abstract][Full Text] [Related]
46. [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group].
Barkai L; Halmos T; Hidvégi T; Jermendy G; Korányi L; Madácsy L; Pados G; Winkler G;
Orv Hetil; 2011 Sep; 152(36):1450-8. PubMed ID: 21865147
[No Abstract] [Full Text] [Related]
47. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk.
Calabro P; Yeh ET
Curr Hypertens Rep; 2008 Feb; 10(1):32-8. PubMed ID: 18367024
[TBL] [Abstract][Full Text] [Related]
48. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
[TBL] [Abstract][Full Text] [Related]
49. The molecular mechanisms between metabolic syndrome and breast cancer.
Chen Y; Wen YY; Li ZR; Luo DL; Zhang XH
Biochem Biophys Res Commun; 2016 Mar; 471(4):391-5. PubMed ID: 26891869
[TBL] [Abstract][Full Text] [Related]
50. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.
Leroith D
Am J Med Sci; 2012 Jan; 343(1):13-6. PubMed ID: 22205060
[TBL] [Abstract][Full Text] [Related]
51. Role of Adipokines in Cardiovascular Disease.
Lau WB; Ohashi K; Wang Y; Ogawa H; Murohara T; Ma XL; Ouchi N
Circ J; 2017 Jun; 81(7):920-928. PubMed ID: 28603178
[TBL] [Abstract][Full Text] [Related]
52. [Fitness versus fatness: respective cardiometabolic impacts at different age ranges].
Esser N; Paquot N; Scheen AJ
Rev Med Liege; 2010 Apr; 65(4):199-205. PubMed ID: 20499822
[TBL] [Abstract][Full Text] [Related]
53. [Metabolic obesity in normal weight individuals and cardiovascular disease].
Nowak M; Grzywa M
Pol Merkur Lekarski; 2011 Aug; 31(182):118-21. PubMed ID: 21936351
[TBL] [Abstract][Full Text] [Related]
54. The metabolic syndrome in children and adolescents.
Zimmet P; Alberti G; Kaufman F; Tajima N; Silink M; Arslanian S; Wong G; Bennett P; Shaw J; Caprio S;
Lancet; 2007 Jun; 369(9579):2059-61. PubMed ID: 17586288
[No Abstract] [Full Text] [Related]
55. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.
Lee YH; Pratley RE
J Cardiopulm Rehabil Prev; 2007; 27(1):2-10. PubMed ID: 17474638
[No Abstract] [Full Text] [Related]
56. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
Halmos T; Suba I
Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
[TBL] [Abstract][Full Text] [Related]
57. Adipokines and hepatic insulin resistance.
Li Y; Ding L; Hassan W; Abdelkader D; Shang J
J Diabetes Res; 2013; 2013():170532. PubMed ID: 23762871
[TBL] [Abstract][Full Text] [Related]
58. Metabolic syndrome: a novel high-risk state for colorectal cancer.
Ishino K; Mutoh M; Totsuka Y; Nakagama H
Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
[TBL] [Abstract][Full Text] [Related]
59. The key role of insulin resistance in the cardiometabolic syndrome.
Gill H; Mugo M; Whaley-Connell A; Stump C; Sowers JR
Am J Med Sci; 2005 Dec; 330(6):290-4. PubMed ID: 16355013
[TBL] [Abstract][Full Text] [Related]
60. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].
Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA
Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
